Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pumilio2 and Staufen2 selectively balance the synaptic proteome.
Schieweck R, Riedemann T, Forné I, Harner M, Bauer KE, Rieger D, Ang FY, Hutten S, Demleitner AF, Popper B, Derdak S, Sutor B, Bilban M, Imhof A, Kiebler MA. Schieweck R, et al. Among authors: demleitner af. Cell Rep. 2021 Jun 22;35(12):109279. doi: 10.1016/j.celrep.2021.109279. Cell Rep. 2021. PMID: 34161769 Free article.
Pumilio2-deficient mice show a predisposition for epilepsy.
Follwaczny P, Schieweck R, Riedemann T, Demleitner A, Straub T, Klemm AH, Bilban M, Sutor B, Popper B, Kiebler MA. Follwaczny P, et al. Dis Model Mech. 2017 Nov 1;10(11):1333-1342. doi: 10.1242/dmm.029678. Epub 2017 Oct 18. Dis Model Mech. 2017. PMID: 29046322 Free PMC article.
Staufen2 deficiency leads to impaired response to novelty in mice.
Popper B, Demleitner A, Bolivar VJ, Kusek G, Snyder-Keller A, Schieweck R, Temple S, Kiebler MA. Popper B, et al. Neurobiol Learn Mem. 2018 Apr;150:107-115. doi: 10.1016/j.nlm.2018.02.027. Epub 2018 Feb 26. Neurobiol Learn Mem. 2018. PMID: 29496644
Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target.
Caldi Gomes L, Hänzelmann S, Hausmann F, Khatri R, Oller S, Parvaz M, Tzeplaeff L, Pasetto L, Gebelin M, Ebbing M, Holzapfel C, Columbro SF, Scozzari S, Knöferle J, Cordts I, Demleitner AF, Deschauer M, Dufke C, Sturm M, Zhou Q, Zelina P, Sudria-Lopez E, Haack TB, Streb S, Kuzma-Kozakiewicz M, Edbauer D, Pasterkamp RJ, Laczko E, Rehrauer H, Schlapbach R, Carapito C, Bonetto V, Bonn S, Lingor P. Caldi Gomes L, et al. Among authors: demleitner af. Nat Commun. 2024 Jun 7;15(1):4893. doi: 10.1038/s41467-024-49196-y. Nat Commun. 2024. PMID: 38849340 Free PMC article.
Parkinson's disease therapy: what lies ahead?
Wolff A, Schumacher NU, Pürner D, Machetanz G, Demleitner AF, Feneberg E, Hagemeier M, Lingor P. Wolff A, et al. Among authors: demleitner af. J Neural Transm (Vienna). 2023 Jun;130(6):793-820. doi: 10.1007/s00702-023-02641-6. Epub 2023 May 5. J Neural Transm (Vienna). 2023. PMID: 37147404 Free PMC article. Review.
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.
Lingor P, Demleitner AF, Wolff AW, Feneberg E. Lingor P, et al. Among authors: demleitner af. J Neural Transm (Vienna). 2022 Sep;129(9):1155-1167. doi: 10.1007/s00702-022-02500-w. Epub 2022 Apr 17. J Neural Transm (Vienna). 2022. PMID: 35434769 Free PMC article. Review.
13 results